TrialMultiple sclerosis (Houndmills, Basingstoke, England)2014
Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis.
Y Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papertrialcites it